/
Gestational Diabetes Mellitus Gestational Diabetes Mellitus

Gestational Diabetes Mellitus - PowerPoint Presentation

ellena-manuel
ellena-manuel . @ellena-manuel
Follow
566 views
Uploaded On 2017-03-18

Gestational Diabetes Mellitus - PPT Presentation

GDM Training Madhya Pradesh 12 April 2016 Presentation title Date 1 Dr Sachin Chittawar DM Endocrinology Diabetes a public health crisis Diabetes and maternal health and pregnancy ID: 525824

gdm diabetes glucose insulin diabetes gdm insulin glucose gestational pregnancy presentation title date amp mellitus guidelines international management pregnant federation diagnosis national

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Gestational Diabetes Mellitus" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Gestational Diabetes Mellitus(GDM)

Training, Madhya Pradesh 1-2 April, 2016

Presentation title

Date

1

Dr

Sachin

Chittawar

DM (Endocrinology)Slide2

Diabetes – a public health crisis

Diabetes and maternal health and pregnancy

Gestational diabetes and pregnancy outcomes

National guidelines for diagnosis and management of GDM

Testing for GDM

Management of GDM

Agenda

Presentation title

Date

2Slide3

Presentation title

Date

3

Diabetes

a public health crisisSlide4

Globally diabetes has reached pandemic status

Presentation titleDate

4

415 million

people have diabetes

1

As of 2015

318 million

people have

prediabetes

*,

1* Prediabetes is the number of people estimated to have impaired glucose tolerance, a precursor to developing type 2 diabetesSource: IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2015 Slide5

Numbers are also rapidly increasing in India

Presentation title

Date

5

Number of adults (20–79) with diabetes in India

2009

1

2015

2

2040

2

124 millionpeople

69 million

people

51

million

people

IDF Diabetes Atlas, 4th

edn

.

Brussels, Belgium: International Diabetes Federation, 2009

IDF

Diabetes Atlas, 7th

edn

.

Brussels, Belgium: International Diabetes Federation, 2015

36 million

people are undiagnosed

(52%)

2Slide6

Diabetes is associated with serious complications

Presentation titleDate

6

Consistently high blood glucose levels can lead to serious disease affecting the heart and blood vessels, eyes, kidneys and nerves

STROKE

Strokes are up to

four times as likely

BLINDNESS

Diabetes

is a

leading cause

of blindness HEART ATTACK Heart attack is three times as likely KIDNEY FAILURE

Total

kidney

failure is three times as likely

AMPUTATION

Diabetes

is a

leading cause

of non-traumatic lower-limb amputations

Source:

IDF Diabetes Atlas, 7th

edn

.

Brussels, Belgium: International Diabetes Federation, 2015 Slide7

The costs to society are high

Presentation titleDate

7

Healthcare costs for people with diabetes are two-

to three-fold higher than for people without diabetes and the costs are increasing

IDF

Diabetes Atlas, 7th

edn

.

Brussels, Belgium: International Diabetes Federation, 2015

IDF

Diabetes Atlas, 4th edn. Brussels, Belgium: International Diabetes Federation, 2009 IDF Diabetes Atlas, 6th edn. Brussels, Belgium: International Diabetes Federation, 2013 * Estimated global diabetes-related healthcare expenditure1

12% of global healthcare expenditure was for diabetes in 2015

Global diabetes healthcare expenditure has increased 79%

since 2009

79%

increase

*

$6.5 billion

in India

2Slide8

Presentation title

Date

8

What does diabetes

have to do with maternal health and pregnancy?Slide9

Hyperglycaemia in pregnancy canbe classified as:

Presentation title

Date

9

Diabetes in Pregnancy (DIP)

Gestational Diabetes (GDM)

Diabetes detected prior to pregnancy

(Type 1 and Type 2)

Diabetes first detected in pregnancy

(Type 1 and Type 2)

Diabetes continues post delivery

Pregnant women who have never had diabetes but who have high blood glucose levels during pregnancy

Transient and disappears after birth

Source:

IDF Diabetes Atlas, 7th

edn

.

Brussels, Belgium: International Diabetes Federation,

2015

Hod

M,

Kapur

A, Sacks DA, et al. The International Federation of

Gynecology

and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care.

International Journal of

Gynecology

and Obstetrics: the official organ of the International Federation of

Gynecology

and Obstetrics.

2015;131:S173.

Slide10

Gestational diabetes is the most common cause of

hyperglycaemia in pregnancy1

Gestational Diabetes

March 2016

10

International Diabetes Federation. IDF Diabetes Atlas, 7th edn

.

Brussels, Belgium: International Diabetes Federation, 2015.

Feig

DS,

Corcoy R, Jensen DM, et al. Diabetes in pregnancy outcomes: A systematic review and proposed codification of definitions. Diabetes/metabolism research and reviews. 2015;31(7):680–690.15% of casesDiabetes in pregnancy2DIP maybe either pre-existing diabetes (type 1 or type 2) antedating pregnancy, or diabetes first detected during pregnancy

85% of cases

Gestational diabetes2

Glucose intolerance with first onset during pregnancy Slide11

Hyperglycaemia

is one of the most common medical conditions associated with pregnancy1

Gestational Diabetes

March 2016

11

International

Diabetes Federation.

IDF Diabetes Atlas, 7th

edn

.

Brussels, Belgium: International Diabetes Federation, 2015.HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study associations with neonatal anthropometrics. Diabetes. 2009;58(2):453-459.

20.9

million live births

are affected by hyperglycaemia in pregnancy1

Globally

30%

(6.2 million)

are in India

1Slide12

Hyperglycaemia in pregnancy in India

Gestational DiabetesMarch 2016

12

International

Diabetes Federation. IDF Diabetes Atlas, 7th

edn. Brussels, Belgium: International Diabetes Federation, 2015.Nielsen, K. K., Damm, P., Kapur, A., Balaji

, V.,

Balaji

, M. S., Seshiah, V., &

Bygbjerg

, I. C. (2016). Risk Factors for

Hyperglycaemia in Pregnancy in Tamil Nadu, India. PloS one, 11(3), e0151311. 6.2 million live births are affected by hyperglycaemia in pregnancy1

5.9 million

are due to GDM

1

Difference in GDM urban/rural distribution

(

Tamil Nadu field

study

2

)

Urban areas

Semi-urban areas

Rural areas

17.8%

13.8

%

9.9%

Of which,

GDM prevalence

27.6%

1Slide13

Presentation title

Date

13

How does GDM impact pregnancy outcomes?Slide14

Food for thought!!!

All are diabetogenic in GDM except1) hPL

2) Progesterone3) GH4) increase in insulin5) Beta cell failure.Slide15

Pre-eclampsiaPolyhydramnios

Prolonged labourObstructed labourCaesarean SectionUterine atony

Postpartum haermorrhageInfection

Gestational diabetes is associated with a number of maternal complications

Presentation title

Date

15

1.

Crowther

CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

New England Journal of Medicine

. 2005;352(24):2477–2486. 2. The HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. 3. Hod

M, Kapur A, Sacks DA, et al. The International Federation of

Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care

. International Journal of Gynecology

and

Obstetrics

: the official organ of the International Federation of

Gynecology

and Obstetrics.

2015;131:S173

.

4.

International Diabetes Federation.

IDF Diabetes Atlas, 7th

edn

.

Brussels, Belgium: International Diabetes Federation, 2015.

5.

Ehrenberg HM,

Durnwald

CP, Catalano P, Mercer BM. The influence of obesity and diabetes on the risk of

cesarean

delivery.

Am J

Obstet

Gynecol.

2004;191(3):969-974.

7.

Rudge

MV, Calderon IM, Ramos MD,

Peracoli

JC,

Pim A. Hypertensive disorders in pregnant women with diabetes mellitus. Gynecol Obstet Invest. 1997;44(1):11-15. 8

.

Yogev

Y,

Xenakis

EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of

glycemic

control.

American journal of obstetrics and

gynecology

.

2004;191(5):1655-1660

.Slide16

Congenital anomaliesIntra Uterine Growth Restriction (IUGR)

Increase in still-birthsMacrosomiaIncreased respiratory problemsJaundiceShoulder dystocia

Birth injuriesNeonatal hypoglycaemiaInfant respiratory distress syndrome

Gestational diabetes is associated with a number of consequences for the foetus

Presentation title

Date

16

1.

Crowther

CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

New England Journal of Medicine

. 2005;352(24):2477–2486. 2. The HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. 3. Hod M,

Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and

care. International Journal

of Gynecology and

Obstetrics

: the official organ of the International Federation of

Gynecology

and Obstetrics.

2015;131:S173

.

4.

International Diabetes Federation.

IDF Diabetes Atlas, 7th

edn

.

Brussels, Belgium: International Diabetes Federation, 2015.

5. Slide17

Children born to mothers with GDM are up to

8-times

more likely to develop type 2 diabetes and obesity

in their teens or early adulthood.

Gestational diabetes also increases the risk for type 2 diabetes in both mother

and childPresentation title

Date

17

Approximately

50% of women

with GDM go on to develop type 2 diabetes

within five year of pregnancy.SOURCES: 1. Kim C, Newton KM, Knopp RH. Gestational Diabetes and the Incidence of Type 2 Diabetes: A Systematic Review, Diabetes Care 25, 2002. 2.

Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes the role of intrauterine hyperglycemia.

Diabetes care.

2008;31(2): 340-346 3. Hod

M,

Kapur

A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO)

l of Gynecology and Obstetrics.

2015;131:S137

4.

International Diabetes Federation.

IDF Diabetes Atlas, 7th

edn

.

Brussels, Belgium: International Diabetes Federation, 2015

.

Slide18

All of this goes hand in hand with a general rise of

the diabetes pandemicPresentation title

Date

18Slide19

Globally recognised risk factors

Gestational diabetes risk factors

Presentation titleDate

19

Personal history of IGT or GDM in a previous pregnancy

Ethnicity

Family history of diabetes, especially in first degree relatives

BMI >30 kg/m

2

Maternal age >25 years of age

Previous delivery of a baby >9 pounds (4.1 kg)Previous unexplained perinatal loss Glycosuria at the first prenatal visitMedical condition/setting associated with development of diabetes, such as metabolic syndrome, polycystic ovary syndrome (PCOS), current use of glucocorticoids, hypertensionSOURCES: 1. Solomon, et al. (1997). A prospective study of pregravid determinants of gestational diabetes mellitus.

Jama, 278(13), 1078-1083.

2. Kim, C, et al. (2009). Does frank diabetes in first-degree relatives of a pregnant woman affect the likelihood of her developing gestational diabetes mellitus or

nongestational diabetes?. American journal of obstetrics and gynecology

,

201

(6), 576-e1.

2.

Hedderson

, et al. (2008). Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus.

American journal of obstetrics and

gynecology

,

198

(4), 409-e1.

R

isk

increases when multiple risk factors are presentSlide20

Food for thought!!!

Exercise increases all exceptInsulin secretion.Insulin independent glucose consumption.

AmP kinase activity.

Insulin resistance.Insulin sensitivity.Slide21

In a recent study (2015) from Tamil

Nadu, globally recognised risk factors were not significant:1

Although risk factors, to some extent,

point to additional risk among certain women, testing according to risk factors would imply missing out on 20-30% of hypoglycaemia in pregnancy cases1

GDM risk factors

Presentation title

Date

21

Source:

Nielsen

, K. K.,

Damm, P., Kapur, A., Balaji, V., Balaji, M. S., Seshiah, V., & Bygbjerg, I. C. (2016). Risk Factors for Hyperglycaemia in Pregnancy in Tamil Nadu, India. PloS one, 11

(3), e0151311.Slide22

“In India… studies indicate that GDM may be associated with increasing socio-economic status, and similar trends have been found for type 2 diabetes.”

GDM risk factors

Presentation title

Date

22

Source: Nielsen

, K. K.,

Damm

, P.,

Kapur

, A.,

Balaji, V., Balaji, M. S., Seshiah, V., & Bygbjerg, I. C. (2016). Risk Factors for Hyperglycaemia in Pregnancy in Tamil Nadu, India. PloS one, 11(3), e0151311.

“…

among women attending the rural health centre a doubling in income caused an 80% increased risk of HIP [hyperglycaemia in pregnancy].” Slide23

Screening and diagnostic testing for diabetes are performed because

identifying pregnant women with diabetes followed by appropriate therapy can decrease feotal and maternal morbidity

, particularly macrosomia, shoulder dystocia,

and pre-eclampsia.

Universal testing for GDM is recommended

1Screening and diagnostic testing

Presentation title

Date

23

Sources: 1

.

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide24

Food for thought!!!

What is optimal blood sugars in pregnancy?Fasting >100,PP >150.Fasting >95,PP >140.Fasting <95,PP <140.Fasting ≤92,PP ≤ 120.

None of the above.Slide25

Presentation title

Date

25

Are there national guidelines for diagnosis and management

of GDM?Slide26

National Guidelines for Diagnosis & Management of Gestational Diabetes Mellitus

Presentation title

Date

26

Available at:

www.nrhmorissa.gov.in

/

writereaddata

/Upload/Documents/National%20Guidelines%20for%20Diagnosis%20

&%20Management%20of%20Gestational%20Diabetes%20Mellitus.pdfSlide27

Testing for GDM

Presentation title

Date

27Slide28

Considering the high prevalence of GDM in India and the maternal & foetal morbidity associated with untreated GDM

all pregnant women should be tested for GDMTesting for GDM

Presentation title

Date

28

Testing for GDM is recommended twice

during

antenatal care (ANC)

First testing done during first ANC contact

Second testing done during 24-28 weeks of pregnancy if first test is negative

There should be at least 4 weeks gap between the two tests

If a woman presents beyond 28 weeks of pregnancy only one test is doneIf the test is positive at any point, protocol management should be followedSource: National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide29

Testing for GDM – protocol of investigations

Presentation title

Date

29

Source: National Guidelines for Diagnosis & Management of Gestational Diabetes Mellitus

All pregnant women in the community

Testing for GDM at 1st Antenatal visit

(75 g oral

glucose -

2

hr

Plasma Glucose value)Manage as GDM

as per guidelines

Negative (2

hr

PG <140mg/dl)

Repeat

Testing at

24-28

weeks

Positive (2

hr

PG ≥ 140 mg/dl

)

Negative (2

hr

PG < 140mg/dl

)

Manage as normal ANC

Manage as GDM

as per guidelines

Positive (2

hr

PG ≥ 140 mg/dl

)Slide30

Single step testing using 75 g Oral Glucose Tolerance Test (OGTT) and measuring plasma glucose 2 hours after ingestion

75 g glucose to be given orally after dissolving in approximately 300 ml water whether woman comes in fasting or non-fasting stateIntake of solution has to be completed within 5 min.A plasma standardised glucometer should be used to evaluate blood glucose 2 hours after the oral glucose load

If vomiting occurs within 30 min of oral glucose intake the test has to be repeated the next day. If vomiting occurs after 30 minutes the test continuesThe threshold plasma glucose level of ≥140 mg/

dL is taken as cut off for diagnosis of GDM

Methodology: Test for diagnosis

Presentation titleDate

30

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide31

Food for thought!!!

True about insulin resistance (IR) ? 1) Increases by 50-60 % in 2-3 rd trimester.

2) Insulin sensitivity increases by 50-60 % in 2-3 rd trimester.

3) IR increases in late first trimester.4) IR decreases in third trimesterSlide32

Management of GDM

Presentation titleDate

32Slide33

GDM is managed initially with Medical Nutrition Therapy (MNT)

and if not controlled with MNT, insulin therapy is added to the MNTManagement of GDM

Presentation title

Date

33

Pregnant woman with GDM

Medical Nutrition Therapy

2

hr

Post Prandial Plasma Glucose (PPPG)

2 weeks

≥ 120

mg/dl

Start Insulin Therapy

< 120 mg/dl

Continue MNT

Monitor FBG & 2

hr

PPPG every

3rd

day

or more frequently

till

Insulin dose adjusted to

maintain

normal plasma glucose

levels

Monitor 2

hr

PPPG

once weekly

Monitor 2

hr

PPPG

Up to 28

wks

: Once in 2

weeks

After 28

wks

: Once a week

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide34

In most cases GDM can be managed by Medical Nutrition Therapy (MNT)Principles of MNT

MNT for GDM primarily involves a carbohydrate controlled balanced meal plan Nutrition assessment should be individualisedMaternal weight gain is the important measure in follow up visits to determine whether energy intake is adequate to support

fetal growth

Medical Nutrition Therapy (MNT)Overall Principles

Presentation title

Date

34

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes Mellitus, page 11.Slide35

Carbohydrate foods are essential for a healthy diet for mother and baby. Once digested, carbohydrate foods are broken down to glucose, which goes into the blood stream. The type, amount and frequency of carbohydrate intake has a major influence on blood glucose readings.

Large amounts of carbohydrate foods eaten at one time will lead to high blood glucose level and should be avoided. It is better to spread carbohydrate foods over 3 small meals and 2-3 snacks each day than taking 3 large meals.

Complex carbohydrates (e.g. whole grain cereals) should be preferred over simple carbohydrates like foods with lots of added sugar or honey or foods that are made from refined white flour.Counting the number of carbohydrates serves that a mother eats during the days will help her to eat the right amount.

Medical Nutrition Therapy (MNT)

Careful Selection of Carbohydrates

Presentation titleDate

35

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes Mellitus, page 11.Slide36

Saturated fat intake (ghee, butter, coconut oil, palm oil, red meat, organ meat, full cream milk etc.) should be less than 10% of total calories and dietary cholesterol should be less than 300 mg/day. In obese and overweight patients, a lower fat diet overall can help slow down the rate of weight gain.

RecommendationsUse less fat in cooking and avoid frying of foodsUsing low-fat dairy products in place of whole milk or full cream products

Choose low-fat snack (e.g. fresh fruit) instead of high-fat snacks (cakes, biscuits etc.)Use lean mean instead of read meat

Medical Nutrition Therapy (MNT)Understanding Fat Intake During Pregnancy

Presentation title

Date

36

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes Mellitus

For more details, see:

Sample Diet Chart and

Food Exchange Chart for MNT in

the National GDM Guidelines.Slide37

When and WhatInsulin therapy is the accepted medical management of pregnant women with GDM not controlled on MNT in 2 weeks

The National Guidelines recommend the use of Human Premix insulin 30/70. Oral tablets for diabetes treatment in pregnancy are not

to be given as they are not considered safe.All pregnant women in whom MNT fails to achieve a 2 hr PPPG <120 mg/

dL are started on insulin, along with MNTIn case of very high 2 hr PPPG:

If 2 hr PPPG is >200 mg/dL at diagnosis, starting dose of insulin should be 8 units pre-mixed insulinThe dose to be adjusted on follow-up and at the same time MNT has been followed. Frequency of monitoring to be decided by the treating Physician/Gynaecologist/Medical Officer.

If the pregnant women requires more than 20 units insulin/day, she should be referred to a higher healthcare centre.Insulin Therapy

Presentation title

Date

37

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide38

Food for thought!!!

Insulin approved in Pregnancy are all except ?Lispro(

Humalog, Humalog

mix25, Humalog

mix 50)Aspart

Detemir , NPH. Glargine , Gluilisin

(

Apidra

),

Degludec

,

Rizodeg.Slide39

Human insulin

pmol

/min

00:00

02:00

04:00

06:00

08:00

10:00

12:00

14:00

16:00

18:00

20:00

22:00

00:00

200

400

Time

22:00

Meals

Adapted from

Polonsky

et al. N

Engl

J Med

1988;318:1231

9

Healthy

insulin

response

Soluble

human

insulin

NPH

insulin

SC

Insulin

repl.

NPH, neutral protamine

Hagedorn

; SC, subcutaneous

Traditional insulin products do not mimic the healthy insulin responseSlide40

Insulin Aspart

: A step ahead…

Periello.

Diabet Med 2005;22:606–11

PPG

Insulin

*p<

0.05

vs.

human insulin

Mean serum glucose (

mmol

/l)

6

8

10

12

14

0

0

30

60

90

120

150

180

210

240

*

Time (min)

100

200

300

400

0

500

600

Insulin (

pmol

/l)

0

30

60

90

120

150

180

210

240

*

Time (min)

Insulin Aspart

Human insulin

Insulin

Aspart

has a more physiological profile compared to Human Insulins with improved PPG controlSlide41

Insulin

aspart

+ NPH (n=157)

HI + NPH

(n=165)

n

E

Rate

n

E

Rate

Major

38

113

1.4

35

174

2.1

Minor

148

7197

86.4

148

7944

94.5

Symptoms only

85

1055

12.7

85

742

8.8

Insulin

aspart

use

in

pregnancy

Better PPG control compared to human insulin

Safe for the mother: fewer Hypoglycaemic episodes during pregnancy

Safe for foetus: Significantly lower risk of preterm deliveries

Overall Better foetal outcomes

Mathiesen

et al. Diabetes Care

2007;30:771–6,

Hod

et al. Am J

Obstet

Gynecol

2008;198:e1–7Slide42

Another Question

Which is correct as per color coding of insulin syringe?1.Red color is 40 IU syringe.2.Orange for 100 IU syringe.3.Blue for 500 IU syringe.

4.None of the above 5.All of the aboveSlide43

Any pregnant woman on insulin can develop hypoglycaemia at any time

Hypoglycaemia is diagnosed when blood glucose level is < 70 mg/dlImportant to recognise symptoms of hypoglycaemia & treat

immediatelyEarly symptoms - Tremors of hands, sweating, palpitations, hunger, easy

fatigability, headache, mood changes, irritability, low attentiveness, tingling sensation

around the mouth/lips or any other abnormal feelingSevere

- Confusion, abnormal behaviour or both, visual disturbances, nervousness or anxiety, abnormal behaviour.

Uncommon

- Seizures and loss of consciousness

Hypoglycaemia

How to Recognise Hypoglycaemia

Presentation titleDate43Source: National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide44

Ask the pregnant women to take 3 TSF of glucose powder (15-20 grams) dissolved in a glass of water

After taking oral glucose, she must take rest & avoid any physical activity15 minutes after taking glucose, she must eat one chapati with vegetable/rice/one

glass of milk/idli/fruits/anything eatable which is availableIf hypoglycaemia continues, repeat same amount of glucose and wait

If glucose is not available, take one of the following: Sugar - 6 TSF in a glass of water/fruit

juice/honey/anything which is sweet/any foodTake rest, eat regularly and check blood glucose if possibleIf the pregnant woman develops >1 episode of

hypoglycaemia in a day, she should consult any doctorimmediatelyHypoglycaemia

How to Manage Hypoglycaemia

Presentation title

Date

44

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide45

Lowering episodes of hypoglycaemia with the use of right insulin therapy

Heller et al.

J Diabetes 2013; 5:482-491

Per-trial and overall analysis of all nocturnal hypoglycaemic episodes

IAsp, insulin

aspart

NPH

, neutral

protamine

Hagedorn

RHI, regular human insulin

0.1

10

Favours

IAsp

+ NPH

Favours RHI + NPH

Trial

Treatment difference

(%) [95% CI]

P

1

Type 1

Type 1 and Type 2

All

Test of heterogeneity:

P

=0.092

Type 2

035

036

064

065

066

1634

037

1198

Fixed effects

Random effects

0.75 [0.60; 0.93]

0.01

0.69 [0.56; 0.86]

<0.001

0.79 [0.59; 1.06]

0.11

0.79 [0.59; 1.06]

0.83 [0.50; 1.38]

0.12

0.97 [0.59; 1.58]

0.89

0.54 [0.24; 1.22]

0.14

0.68 [0.16; 2.85]

0.59

0.76 [0.67; 0.85]

<0.001

0.76 [0.67; 0.85]

<0.001

0.48

Lower rate of nocturnal

hypoglycaemic

episodes with insulin

aspart

vs human insulin Slide46

Antenatal care of a pregnant woman with GDM should be provided by

a gynaecologist, if available.If GDM is diagnosed before 20 weeks of pregnancy, a foetal anatomical survey by USG should be performed at 18-20 weeks.

For all pregnancies with GDM, a foetal growth scan should be performed at 28-30 weeks gestation & repeated at 34-36 weeks gestation.

There should be at least 3 weeks gap between the two ultrasounds and it should include

fetal biometry & amniotic fluid estimation.Pregnant women with GDM in whom blood glucose level is well controlled and there are

no complications, should go for routine antenatal care as per GoI guidelines.In pregnant women with GDM having uncontrolled blood glucose level or any

other complication

of pregnancy, the frequency of antenatal visits should

be increased

to every 2 weeks in second trimester

and

every week in third trimester.Monitor for abnormal foetal growth (macrosomia/growth restriction) and polyhydramnios at each ANC visit PW with GDM to be diligently monitored for hypertension in pregnancy, proteinuria and other obstetric complicationsIn pregnant women with GDM between 24-34 weeks of gestation and requiring early delivery, antenatal steroids should be given as per GoI guidelines i.e. Inj. Dexamethasone 6 mg IM 12 hourly for 2 days. More vigilant monitoring of blood glucose levels should be done for next 72 hours following injection. In case of raised blood glucose levels during this period, adjustment of insulin dose should be made accordingly.

Special Obstetric Care for Women with GDM

Antenatal Care

Presentation title

Date

46

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide47

Pregnant women with GDM are at an increased risk for foetal

death in utero and this risk is increased in PW requiring medical management. Hence vigilant foetal surveillance is required.Foetal

heart should be monitored by auscultation on each antenatal visit.The pregnant woman should be explained about Daily Fetal Activity

AssessmentWoman to lie down on her side after a meal and note

how long it takes for the foetus to kick 10 times. If the foetus does not kick 10 times within 2 hrs, she should immediately consult a

healthcare worker and if required should be referred to a higher centre for further evaluation.

Foetal surveillance in pregnant

w

oman with GDM

Presentation title

Date

47Source: National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide48

Pregnant women with GDM with good control of

blood glucose (2 hr PPPG < 120 mg/dl) levels may be delivered at their respective health facility.Pregnant women with GDM on insulin therapy with uncontrolled blood glucose

levels (2 hr PPPG ≥120 mg/dl) or insulin requirement >20 U/day should be referred for delivery at

CEmOC centres under care of gynaecologist

at least a week before the planned delivery.Such referred cases must get assured indoor admission or can be kept in a birth waiting home with round the clock availability of

medical staff for monitoring.Timing of delivery

GDM pregnancies are associated with delay in lung maturity of the foetus; so routine delivery prior to 39 weeks is not recommended.

If

a

woman with

GDM with well controlled plasma glucose has not

already delivered spontaneously, induction of labour should be scheduled at or after 39 weeks of pregnancy.In woman with GDM with poor plasma glucose control, those with risk factors like hypertensive disorder of pregnancy, previous still birth and other complications should be delivered earlier. The timing of delivery should be individualised by the obstetrician accordingly.Vaginal delivery should be preferred and LSCS should be done for obstetric indications only.In case of foetal macrosomia (estimated foetal weight > 4 Kg) consideration should be given for a primary

caesarean section at 39 weeks

to avoid shoulder dystocia.Labour and Delivery

Presentation title

Date

48

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide49

Pregnant women with GDM on insulin

require plasma glucose monitoring during labour by a glucometer.The morning dose of insulin is withheld on the day of

induction/labour and the PW should be started on 2 hourly monitoring of plasma glucose.

IV infusion with normal saline (NS) to be started and regular insulin to be

added according to blood glucose levels as per the table to t to the right

Special precaution during labour

Presentation title

Date

49

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide50

All babies born to mothers with GDM are at risk for development of hypoglycaemia

irrespective of treatment whether they are on insulin or not and should be observed closely. All babies

are, hence, to be checked for hypoglycaemia at or within one hour of delivery by glucometer.

All neonates should receive immediately essential newborn care

with emphasis with early breastfeeding to prevent hypoglycaemia.If required, the sick neonates should be immediately resuscitated

as per GoI guidelines.Newborn should be monitored for hypoglycaemia (capillary

blood glucose

<44 mg/dl). Monitoring should be started at 1 hour of

delivery and

continued every 4 hours (prior to next feed) till four stable

glucose values

are obtained.Neonate should be also be evaluated for other neonatal complications like respiratory distress, convulsions, hyperbilirubinaemia.Further details are found in the National GuidelinesImmediate neonatal care for baby of mother with GDMPresentation titleDate

50

Source:

National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide51

Immediate postpartum care women with GDM is not different from women without GDM but these women are at high risk to develop

Type 2 Diabetes mellitus in future.Maternal glucose levels usually return to normal after delivery.Nevertheless, a FPG & 2 hr PPPG is performed on the 3rd day

of delivery at the place of delivery. For this reason, GDM cases are not discharged after 48 hours unlike other normal PNC cases.

6 weeks post partum: 75 g GTT at 6 weeks to evaluate glycaemic status of woman.

Cut offs for normal blood glucose values are:

Fasting plasma glucose: ≥ 126 mg/dl75 g OGTT 2 hour plasma glucoseNormal: < 140 mg/dl

IGT

: 140-199mg/dl

Diabetes

: ≥ 200 mg/dl

Post-delivery follow-up of women with GDM

Presentation titleDate51Source: National Guidelines for Diagnosis & Management of Gestational Diabetes MellitusSlide52

Food for thought!!!

DM after pregnancy(post delivery) ? upto 50 %10%5%

1%Slide53

Bringing blood glucose in good control is almost entirely in the hands of the pregnant woman with GDM

It is important that:The pregnant woman understands both the short- and the long-term potential consequences of her

condition (for her and her unborn child) Her family (husband and in-laws) understand what GDM is and why a change in the woman’s/family’s dietary habits may be necessary

The pregnant woman understands the importance of attending the clinic for observation and follow-upThe pregnant woman understands that, while GDM is transitional, both her and her child at at increased risk of type 2 diabetes in the future

Patient Education - Key to good outcomes

Presentation title

Date

53Slide54

Additional and detailed information and guidance is available

Presentation titleDate

54

Available at:

www.nrhmorissa.gov.in

/

writereaddata

/Upload/Documents/National%20Guidelines%20for%20Diagnosis%20

&%20Management%20of%20Gestational%20Diabetes%20Mellitus.pdf

National Guidelines for Diagnosis & Management of Gestational Diabetes Mellitus

Includes detailed information on:

EvidenceTechnical guidelines on testing & management of GDMOperational aspects of GDM Programme

Records & Registers

Monitoring and Quality Assurance

Outcome measures to be assessed

Tools and resources related to:

MNT, reporting, Migration

form, Referral slip, Glucometer specifications and calibrationSlide55

Together we can ensure better maternal health and pregnancy outcomes

...

and curb the increasing type 2 diabetes epidemic

Presentation title

Date

55